EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumors

Aman Chauhan, Kelley Chan, Thorvardur R Halfdanarson, Andrew M Bellizzi, Guido Rindi, Dermot O'Toole, Phillip S Ge, Dhanpat Jain, Arvind Dasari, Daniel A Anaya, Emily Bergsland, Erik Mittra und 9 weitere

CA: A Cancer Journal for Clinicians · 2024-07 · 74 (4) · 359-367

DOI: 10.3322/caac.21840 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift CA: A Cancer Journal for Clinicians, online erschienen am 29.04.2024. Verfasst von Aman Chauhan und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Neuroendocrine Oncology, Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, Florida, USA. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Neoplasm Staging, Pancreatic Neoplasms, Stomach Neoplasms. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The American Joint Committee on Cancer (AJCC) staging system for all cancer sites, including gastroenteropancreatic neuroendocrine tumors (GEP‐NETs), is meant to be dynamic, requiring periodic updates to optimize AJCC staging definitions. This entails the collaboration of experts charged with evaluating new evidence that supports changes to each staging system. GEP‐NETs are the second most prevalent neoplasm of gastrointestinal origin after colorectal cancer. Since publication of the AJCC eighth edition, the World Health Organization has updated the classification and separates grade 3 GEP‐NETs from poorly differentiated neuroendocrine carcinoma. In addition, because of major advancements in diagnostic and therapeutic technologies for GEP‐NETs, AJCC version 9 advocates against the use of serum chromogranin A for the diagnosis and monitoring of GEP‐NETs. Furthermore, AJCC version 9 recognizes the increasing role of endoscopy and endoscopic resection in the diagnosis and management of NETs, particularly in the stomach, duodenum, and colorectum. Finally, T1NXM0 has been added to stage I in these disease sites as well as in the appendix.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsNeoplasm StagingPancreatic NeoplasmsStomach NeoplasmsIntestinal NeoplasmsHumansUnited States

Stichwörter der Autor:innen

American Joint Committee on Cancer (AJCC) version 9cancer staging protocolsgastroenteropancreatic neuroendocrine tumorsgastrointestinal neuroendocrine tumorpancreatic neuroendocrine tumor

Autor:innen und Institutionen

  • Department of Medicine, Neuroendocrine Oncology, Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, Florida, USA.
  • Department of Surgery, Loyola University Medical Center, Chicago, Illinois, USA.
  • Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Pathology, University of Iowa, Carver College of Medicine, Iowa City, Iowa, USA.
  • Department of Life Sciences, Section of Anatomic Pathology, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Department of Woman and Child Health Sciences and Public Health, Anatomic Pathology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS and Roma-Gemelli European Neuroendocrine Tumor Society Center of Excellence…

ORCID-Profile: Elliot A Asare, Chanjuan Shi

Förderung

  • NCI NIH HHS

Zitieren

APA

Chauhan, A., Chan, K., Halfdanarson, T. R., Bellizzi, A. M., Rindi, G., O'Toole, D., Ge, P. S., Jain, D., Dasari, A., Anaya, D. A., Bergsland, E., Mittra, E., Wei, A. C., Hope, T. A., Kendi, A. T., Thomas, S. M., Flem, S., Brierley, J., Asare, E. A., …, & Shi, C. (2024). Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumors. CA: A Cancer Journal for Clinicians, 74(4), 359-367. https://doi.org/10.3322/caac.21840

Vancouver

Chauhan A, Chan K, Halfdanarson TR, Bellizzi AM, Rindi G, O'Toole D, et al. Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumors. CA: A Cancer Journal for Clinicians. 2024;74(4):359-367. doi:10.3322/caac.21840

BibTeX
@article{Chauhan2024,
  author = {Chauhan, Aman and Chan, Kelley and Halfdanarson, Thorvardur R and Bellizzi, Andrew M and Rindi, Guido and O'Toole, Dermot and Ge, Phillip S and Jain, Dhanpat and Dasari, Arvind and Anaya, Daniel A and Bergsland, Emily and Mittra, Erik and Wei, Alice C and Hope, Thomas A and Kendi, Ayse T and Thomas, Samantha M and Flem, Sherlonda and Brierley, James and Asare, Elliot A and Washington, Kay and Shi, Chanjuan},
  title = {Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumors},
  journal = {CA: A Cancer Journal for Clinicians},
  year = {2024},
  volume = {74},
  number = {4},
  pages = {359--367},
  doi = {10.3322/caac.21840}
}
Kostenlos starten →